E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 11/8/2005 in the Prospect News Biotech Daily and Prospect News PIPE Daily.

New Issue: Clearant gets agreements for $12 million private placement of stock

By Sheri Kasprzak

New York, Nov. 8 - Clearant, Inc. said it received definitive agreements for a $12,001,320 private placement.

The offering includes 3,774,000 shares at $3.18 each and is expected to close in the next several days, according to a statement from the company.

The company will also issue warrants for 1,699,000 shares. Neither the strike price nor the expiration date for the warrants could be determined by press time Tuesday.

Los Angeles-based Clearant is a biotechnology company focused on developing sterilization methods to kill pathogens.

Issuer:Clearant, Inc.
Issue:Stock
Amount:$12,001,320
Shares:3,774,000
Price:$3.18
Warrants:For 1,699,000 shares
Announcement date:Nov. 8
Stock price:$3.81 at close Nov. 8

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.